Researchers developed an AI-powered method to detect tumor DNA in blood with high sensitivity, predicting cancer recurrence early. The technology, called MRD-EDGE, uses machine learning to analyze DNA sequencing data from patient blood tests. This method showed success in detecting cancer recurrence in lung, melanoma, breast, and colorectal cancer patients. MRD-EDGE was also able to detect precancerous colorectal polyps. The study demonstrated the potential for earlier detection of cancer recurrence and monitoring tumor response during therapy. The technology could improve cancer care by providing early detection and tracking of tumor DNA. The researchers are excited about its potential for clinical use.
Source link
AI-based liquid biopsy technology promises early detection of cancer recurrence
